TD Waterhouse Canada’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Buy
971
+436
+81% +$118K ﹤0.01% 977
2025
Q4
$134K Sell
535
-15
-3% -$3.98K ﹤0.01% 975
2025
Q3
$153K Hold
550
﹤0.01% 930
2025
Q2
$145K Sell
550
-43
-7% -$10.5K ﹤0.01% 887
2025
Q1
$138K Sell
593
-357
-38% -$86.6K ﹤0.01% 865
2024
Q4
$218K Buy
950
+357
+60% +$81.9K ﹤0.01% 773
2024
Q3
$130K Hold
593
﹤0.01% 847
2024
Q2
$120K Buy
593
+29
+5% +$5.9K ﹤0.01% 853
2024
Q1
$120K Buy
564
+14
+3% +$3.08K ﹤0.01% 866
2023
Q4
$124K Buy
550
+300
+120% +$63K ﹤0.01% 762
2023
Q3
$49.9K Buy
250
+60
+32% +$12.7K ﹤0.01% 916
2023
Q2
$34K Buy
190
+15
+9% +$2.91K ﹤0.01% 1016
2023
Q1
$34.6K Hold
175
﹤0.01% 990
2022
Q4
$35.7K Sell
175
-1,531
-90% -$299K ﹤0.01% 969
2022
Q3
$411K Buy
1,706
+204
+14% +$41.8K ﹤0.01% 553
2022
Q2
$394K Buy
1,502
+1,409
+1,515% +$300K ﹤0.01% 590
2022
Q1
$21.1K Buy
+93
New +$21.9K ﹤0.01% 1169

Other funds holding LH

TD Waterhouse Canada's LH Position: Q1 2026 in Review

TD Waterhouse Canada increased its Labcorp (LH) stake by 81% in Q1 2026, buying an estimated $118K and bringing the position to 971 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

TD Waterhouse Canada first reported a position in LH in Q1 2022 and has held it in 17 quarters since. The position peaked at $411K in Q3 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • TD Waterhouse Canada held 971 shares of Labcorp worth $265K as of Q1 2026.
  • TD Waterhouse Canada bought 436 Labcorp shares in Q1 2026, an estimated $118K.
  • Labcorp made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #977 holding.
  • TD Waterhouse Canada first reported a position in Labcorp in Q1 2022 and has held it in 17 quarters since.
  • TD Waterhouse Canada's Labcorp position peaked at $411K in Q3 2022.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.